Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Fenoglio

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Frontiers in Nephrology|September 7, 2023
The need for kidney biopsy in the management of side effects of target and immunotherapyRoberta Fenoglio, Martina Cozzi, Giulio Del Vecchio, et al.
Journal of Nephrology|July 1, 2008
Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awarenessCaterina Canavese, M Cristina Mereu, Silvio Aime, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 26, 2023
[Cancer and the Kidney: A Deadly Embrace]Dario Roccatello, Simone Cortazzi, Francesca Bertinetto, et al.
Clinical Kidney Journal|August 2, 2023
Focal segmental glomerular sclerosis can be effectively treated using an intensive B-cell depletion therapyDario Roccatello, Alessandra Baffa, Carla Naretto, et al.
Clinical Kidney Journal|May 8, 2026
Unveiling the silent burden: high prevalence of occult nephropathies in radical nephrectomy specimensRoberta Fenoglio, Eleonora Mantovani, Simone Cortazzi, et al.
Immunologic Research|July 25, 2016
Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literatureRoberta Fenoglio, Carla Naretto, Bruno Basolo, et al.
Oncotarget|July 11, 2018
Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndromeRoberta Fenoglio, Savino Sciascia, Giulietta Beltrame, et al.
European Journal of Clinical Investigation|October 31, 2020
Endothelial dysfunction and cardiovascular risk in lupus nephritis: New roles for old players?Daniele Mancardi, Elisa Arrigo, Martina Cozzi, et al.
Autoimmunity Reviews|July 15, 2020
Towards a novel target therapy for renal diseases related to plasma cell dyscrasias: The example of AL amyloidosisDario Roccatello, Roberta Fenoglio, Simone Baldovino, et al.
Nephron|March 21, 2022
Renal Involvement in Transthyretin Amyloidosis: The Double Presentation of Transthyretin Amyloidosis Deposition DiseaseRoberta Fenoglio, Simone Baldovino, Antonella Barreca, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Frontiers in Nephrology|September 7, 2023
The need for kidney biopsy in the management of side effects of target and immunotherapyRoberta Fenoglio, Martina Cozzi, Giulio Del Vecchio, et al.
Journal of Nephrology|July 1, 2008
Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awarenessCaterina Canavese, M Cristina Mereu, Silvio Aime, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 26, 2023
[Cancer and the Kidney: A Deadly Embrace]Dario Roccatello, Simone Cortazzi, Francesca Bertinetto, et al.
Clinical Kidney Journal|August 2, 2023
Focal segmental glomerular sclerosis can be effectively treated using an intensive B-cell depletion therapyDario Roccatello, Alessandra Baffa, Carla Naretto, et al.
Clinical Kidney Journal|May 8, 2026
Unveiling the silent burden: high prevalence of occult nephropathies in radical nephrectomy specimensRoberta Fenoglio, Eleonora Mantovani, Simone Cortazzi, et al.
Immunologic Research|July 25, 2016
Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literatureRoberta Fenoglio, Carla Naretto, Bruno Basolo, et al.
Oncotarget|July 11, 2018
Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndromeRoberta Fenoglio, Savino Sciascia, Giulietta Beltrame, et al.
European Journal of Clinical Investigation|October 31, 2020
Endothelial dysfunction and cardiovascular risk in lupus nephritis: New roles for old players?Daniele Mancardi, Elisa Arrigo, Martina Cozzi, et al.
Autoimmunity Reviews|July 15, 2020
Towards a novel target therapy for renal diseases related to plasma cell dyscrasias: The example of AL amyloidosisDario Roccatello, Roberta Fenoglio, Simone Baldovino, et al.
Nephron|March 21, 2022
Renal Involvement in Transthyretin Amyloidosis: The Double Presentation of Transthyretin Amyloidosis Deposition DiseaseRoberta Fenoglio, Simone Baldovino, Antonella Barreca, et al.
Pageof 11